» Articles » PMID: 37760915

Acyl-Carnitines Exert Positive Effects on Mitochondrial Activity Under Oxidative Stress in Mouse Oocytes: A Potential Mechanism Underlying Carnitine Efficacy on PCOS

Abstract

Carnitines play a key physiological role in oocyte metabolism and redox homeostasis. In clinical and animal studies, carnitine administration alleviated metabolic and reproductive dysfunction associated with polycystic ovarian syndrome (PCOS). Oxidative stress (OS) at systemic, intraovarian, and intrafollicular levels is one of the main factors involved in the pathogenesis of PCOS. We investigated the ability of different acyl-carnitines to act at the oocyte level by counteracting the effects of OS on carnitine shuttle system and mitochondrial activity in mouse oocytes. Germinal vesicle (GV) oocytes were exposed to hydrogen peroxide and propionyl-l-carnitine (PLC) alone or in association with l-carnitine (LC) and acetyl-l-carnitine (ALC) under different conditions. Expression of carnitine palmitoyltransferase-1 (Cpt1) was monitored by RT-PCR. In in vitro matured oocytes, metaphase II (MII) apparatus was assessed by immunofluorescence. Oocyte mitochondrial respiration was evaluated by Seahorse Cell Mito Stress Test. We found that Cpt1a and Cpt1c isoforms increased under prooxidant conditions. PLC alone significantly improved meiosis completion and oocyte quality with a synergistic effect when combined with LC + ALC. Acyl-carnitines prevented Cpt1c increased expression, modifications of oocyte respiration, and ATP production observed upon OS. Specific effects of PLC on spare respiratory capacity were observed. Therefore, carnitine supplementation modulated the intramitochondrial transfer of fatty acids with positive effects on mitochondrial activity under OS. This knowledge contributes to defining molecular mechanism underlying carnitine efficacy on PCOS.

Citing Articles

NAD Metabolism and Mitochondrial Activity in the Aged Oocyte: Focus on the Effects of NAMPT Stimulation.

Emidio G, Vergara T, Konstantinidou F, Flati I, Stuppia L, Artini P Aging Dis. 2024; 15(6):2828-2851.

PMID: 39325941 PMC: 11567263. DOI: 10.14336/AD.2024.0241.


Metabolomic Analysis of Follicular Fluid in Normal-Weight Patients with Polycystic Ovary Syndrome.

Yu J, Wei Y, Zhang Z, Chen J, Fu R, Ye P Biomedicines. 2024; 12(8).

PMID: 39200274 PMC: 11352029. DOI: 10.3390/biomedicines12081810.


Ovarian aging: energy metabolism of oocytes.

Bao S, Yin T, Liu S J Ovarian Res. 2024; 17(1):118.

PMID: 38822408 PMC: 11141068. DOI: 10.1186/s13048-024-01427-y.

References
1.
Shukla P, Mukherjee S . Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome. Mitochondrion. 2020; 52:24-39. DOI: 10.1016/j.mito.2020.02.006. View

2.
Jiang N, Xing B, Peng R, Shang J, Wu B, Xiao P . Inhibition of Cpt1a alleviates oxidative stress-induced chondrocyte senescence via regulating mitochondrial dysfunction and activating mitophagy. Mech Ageing Dev. 2022; 205:111688. DOI: 10.1016/j.mad.2022.111688. View

3.
Lewis N, Hinrichs K, Leese H, McG Argo C, Brison D, Sturmey R . Energy metabolism of the equine cumulus oocyte complex during in vitro maturation. Sci Rep. 2020; 10(1):3493. PMC: 7044441. DOI: 10.1038/s41598-020-60624-z. View

4.
Liao D, Liu X, Yuan X, Feng P, Ouyang Z, Liu Y . Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2021; 38(2):110-115. DOI: 10.1080/09513590.2021.1988559. View

5.
Gonzalez F . Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2011; 77(4):300-5. PMC: 3309040. DOI: 10.1016/j.steroids.2011.12.003. View